Association of serum ferritin in patients with acute ischemic stroke in tertiary care hospital
DOI:
https://doi.org/10.18203/2349-3933.ijam20231870Keywords:
Serum ferritin, Ischemic stroke, Modified Rankin scale, Stroke severity, NIHSS scale, Mortality predictorsAbstract
Background: Stroke is a major cause of mortality and morbidity globally. Identifying prognostic markers and mortality predictors is essential for successful intervention and treatment of ischemic stroke. The study aims to examine the role of serum ferritin as a prognostic indicator for stroke severity in conjunction with national institute of health stroke scale (NIHSS) and MRS stroke scales. Furthermore, the association of serum ferritin and several associated risk factors for stroke was also studied.
Methods: This study conducted was cross-sectional. 143 patients with acute ischemic stroke who attended the general medicine OPD within 24 hours of admission after the onset of stroke were taken into consideration. Only those patients who matched the inclusion and exclusion criteria were taken for analysis. Acute ischemic stroke patients were admitted with verbal consent, medical background, routine blood, neurological examination, and CT scan, NIHSS scoring, treatment protocols, anti-edema measures, and modified Rankin scale for functional recovery after four weeks.
Results: In the present study, 80% were males, and 20% were females. Most study participants were 51-60 years (38%). The mean age is 58.87 years, and the standard deviation is 11.41. About 35% were smokers, 38% were alcoholics, 56% were diabetic, 68% were hypertensives, and 35% had lipid disorders. There is a statistically significant correlation between serum ferritin and the severity of stroke based on the NIHSS scale and the Modified Rankin scale.
Conclusions: The study demonstrates the use of serum ferritin as an indicative marker for prognosis patients having an acute ischemic stroke. However, monitoring during follow-up did not show any benefit. The current study glorifies the simplistic use of a serum marker.
References
Razaaq A, Abdelelah H. A Short Review: Genetic Risk Factors of Stroke. J Uni Anbar Pure Sci. 2021;15:20-26.
Aho K, Harmsen P, Hatano S, Marquardsen J, Smirnov VE, Strasser T. Cerebrovascular disease in the community: results of a WHO collaborative study. Bull World Health Organ. 1980;58:113-30.
Sacco RL, Kasner SE, Broderick JP, Caplan LR, Connors JJB, Culebras A et al. An updated definition of stroke for the 21st century: statement for healthcare professionals from the American Heart Association/American Stroke Association: A statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44:2064-89.
Feigin VL, Forouzanfar MH, Krishnamurthi R, Mensah GA, Connor M, Bennett DA et al. Global Burden of Diseases, Injuries, and Risk Factors Study 2010 (GBD 2010) and the GBD Stroke Experts Group. The global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet. 2014;383:245-54.
World Health Organisation. Stroke and Cerebrovascular accidents. Available at: https://www.emro.who.int/health-topics/stroke-cerebrovascular-accident/index.html. Accessed on 258 March, 2023.
Pandian JD, Sudhan P. Stroke epidemiology and stroke care services in India. J Stroke. 2013;15:128-34.
Sharif S, Ghaffar S, Saqib M, Naz S. Analysis of hematological parameters in patients with ischemic stroke. Endocrinol Metab Int J. 2020;8:17-20.
Fan L, Gui L, Chai E-Q, Wei C-J. Routine hematological parameters are associated with short- and long-term prognosis of patients with ischemic stroke. J Clin Lab Anal. 2018;32.
Ye WY, Li J, Li X, Yang XZ, Weng YY, Xiang WW et al. Predicting the one-year prognosis and mortality of patients with acute ischemic stroke using red blood cell distribution width before intravenous thrombolysis. Clin Interv Aging. 2020;15:255-63.
Wang W, Knovich MA, Coffman LG, Torti FM, Torti SV. Serum ferritin: Past, present and future. Biochim Biophys Acta. 2010;1800:760-9.
Millán M, Sobrino T, Arenillas JF, Rodríguez-Yáñez M, García M, Nombela F et al. Biological signatures of brain damage associated with high serum ferritin levels in patients with acute ischemic stroke and thrombolytic treatment. Dis Markers. 2008;25:181-8.
Franchini M, Targher G, Montagnana M, Lippi G. Iron and thrombosis. Ann Hematol. 2008;87:167-73.
Garg R, Aravind S, Kaur S, Singh Chawla SP, Aggarwal S, Goyal G. Role of serum ferritin as a prognostic marker in acute ischemic stroke: A preliminary observation. Ann Afr Med. 2020;19:95-102.
Van der A DL, Grobbee DE, Roest M, Marx JJM, Voorbij HA, van der Schouw YT. Serum ferritin is a risk factor for stroke in postmenopausal women. Stroke. 2005;36:1637-41.
Egovindarajulu K, Maaran AT, Prathiba P, Saiprashanth PR. A study on the prognostic significance of serum ferritin in patients with acute ischemic stroke. IOSR J Dent Med Sci. 2016;15:31-9.
Koul RK, Yaseen Y, Amreen S, Shah PA, Hakeem MM. Role of serum ferritin in determining the severity and prognosis of stroke: A hospital-based study. Int J Sci Stud. 2017;6:142-5.
Pankaj P, Das M, Sing MK. Association between level of serum ferritin and outcome of patients of stroke. J Evol Med Dent. 2015;4:2023-36.
Narayan M, Singh SK. Study of association between serum ferritin and prognosis of patients in acute ischemic and haemorrhagic stroke. J Dent Med Sci. 2018;17:46-56.
Erdemoglu AK, Ozbakir S. Serum ferritin levels and early prognosis of stroke. Eur J Neurol. 2002;9:633-7.
Demerdash H, Mansour O, Zytoun T, Megahed M. Importance of ferritin in sera and cerebrospinal fluid as both a predictive and an etiodiagnostic biomarker in ischemic stroke: A single-centre prospective study. Res Opin Anesth Intensive Care. 2016;3:74-9.